The Role of Injection Therapy: From 1st Generation to 4th Generation

Shoulder injection therapy has evolved dramatically over the past 20 years. What was once simply 'a cortisone shot' has expanded into a spectrum of treatments with very different mechanisms and applications. Understanding the generations helps explain why some patients fail injection after injection — and what might actually work for them.

1st Generation: Steroid injections

Corticosteroids reduce inflammation powerfully and rapidly. For acute bursitis or acute inflammatory flares, they are highly effective. However, steroids do not repair structural damage. Repeated steroid injections weaken tendon tissue and carry risks of tendon rupture. They are appropriate as short-term pain management, not as a primary treatment for structural pathology.

2nd Generation: PDRN and growth factor injections

PDRN (polydeoxyribonucleotide, extracted from salmon DNA) promotes cell regeneration and has anti-inflammatory properties. It represents a step forward from pure pain management toward tissue recovery. However, it is still a single-ingredient approach and may be insufficient for significant structural damage.

3rd Generation: Structural treatments beyond injection

This generation moves from injection into structural intervention: calcific aspiration physically removes calcium, plication suture physically anchors torn tendons, and bone marrow stimulation activates autologous stem cells. These are not 'injections' in the traditional sense — they are procedures that create structural change.

4th Generation: Patented composite regeneration formulas

Dr. Lee's patented ligament regeneration injection (Patent No. 10-2855611) represents the current frontier: a composite of multiple regeneration-proven components combined in a scientifically optimized formula, administered with micro-current stimulation and bone marrow stimulation technique. The combination, rather than any single ingredient, is the key innovation.